3DMed Onco Core™ and BRCA1 and BRCA2 Gene Mutation Detection Test
Method: Molecular Diagnostic Test
Principle: Next Generation Sequencing
3D Medicines (3DMed) is one of the first companies to provide oncology precision medical testing services in China.
● Tissue panel
3DMed Onco Core™ Tissue Kit(10 genes+MSI) for IVD
3DMed Onco Core™ Tissue Kit(35 genes+MSI) for RUO
Cancer Type: Solid tumors such as non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and gastrointestinal stromal tumor (GIST)
Detectable variant form: SNV/Indel/Fusion, Not included CNV
Performance Characteristics:
– 2% VAF for SNV and Indels in 25ng DNA,
– 100 copies for fusion in 25ng RNA
Library Construction Method: Amplicon Based
● Germline panel
3DMed BRCA1 and BRCA2 Gene Mutation Detection Kit
– Cancer Type: Ovarian Cance, Breast Cancer
– Package: 12 tests/kit
– Specimen Type: Peripheral blood samples (EDTA anticoagulant)
– Target Region: All coding exons and intron/exon junction of BRCA1 and BRCA2 genes (士20 bp)
To visit website, click here